Max Healthcare Institute Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Max Healthcare Institute şirketinin toplam hissedar öz sermayesi ₹84.1B ve toplam borcu ₹13.0B olup, bu da borç-öz sermaye oranını 15.4% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹120.0B ve ₹35.9B dir. Max Healthcare Institute 'in FAVÖK'ü ₹12.8B faiz karşılama oranı -14.7 dur. Şirketin ₹11.0B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

15.4%

Borç/özkaynak oranı

₹12.99b

Borç

Faiz karşılama oranı	-14.7x
Nakit	₹10.99b
Eşitlik	₹84.08b
Toplam yükümlülükler	₹35.92b
Toplam varlıklar	₹120.00b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 543220 'nin kısa vadeli varlıkları ( ₹17.1B ) kısa vadeli yükümlülüklerini ( ₹12.5B ) aşıyor.

Uzun Vadeli Yükümlülükler: 543220 'un kısa vadeli varlıkları ( ₹17.1B ) uzun vadeli yükümlülüklerini ( ₹23.4B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 543220 'nin net borç/öz sermaye oranı ( 2.4% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 543220 'nin borç/öz sermaye oranı son 5 yılda 104.1% seviyesinden 15.4% seviyesine düştü.

Borç Kapsamı: 543220 'nin borcu işletme nakit akışı ( 86.4% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 543220 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Max Healthcare Institute Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Max Healthcare Institute Limited Cessation of Gautam Wadhwa as Director

Max Healthcare Institute Limited (BSE:543220) completed the acquisition of 63.65% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for INR 4 billion.

Max Healthcare Institute Limited Appoints Kummamuri Narasimha Murthy as an Independent Director

Max Healthcare Institute Limited Announces Declaration of Final Dividend

Max Healthcare Institute Limited (BSE:543220) entered into a Strategic Collaboration Agreement to acquire 64% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for an enterprise value of INR 16.6 billion.

Insufficient new directors

Max Healthcare Institute Limited to Report Q2, 2025 Results on Nov 06, 2024

Upcoming dividend of ₹1.50 per share

Max Healthcare Institute Limited, Annual General Meeting, Sep 20, 2024

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q1, 2025 Results on Aug 01, 2024

Max Healthcare Institute Limited Recommends Final Dividend for the Financial Year 2023-24

Full year 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q4, 2024 Results on May 22, 2024

Max Healthcare Institute Limited (BSE:543220) agreed to acquire Alexis Multi-speciality Hospital Private Limited for approximately INR 3720 million.

Price target increased by 11% to ₹767

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Nine Months, 2024 Results on Jan 31, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q2, 2024 Results on Nov 06, 2023

Max Healthcare Institute Limited Approves the Declaration of Final Dividend for the Financial Year Ended March 31, 2023

Max Healthcare Institute Limited Announces Change in Management

Max Healthcare Institute Limited Provides Update on Petition Filed by the Company Against Touch Healthcare Private Limited and Others

Max Healthcare Institute Limited, Annual General Meeting, Sep 27, 2023

Max Healthcare Institute Limited Announces Appointment of Amrita Gangotra as Additional Director (Non-Executive and Independent Woman Director)

Price target increased by 7.1% to ₹611

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q1, 2024 Results on Aug 07, 2023

Aster Eye $300 million India Stake Sale

Price target increased by 8.1% to ₹564

Full year 2023 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q4, 2023 Results on May 16, 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 12%

Max Healthcare Institute Limited Announces Executive Changes

Max Healthcare Institute Limited to Report Q3, 2023 Results on Feb 02, 2023

Blackstone, CVC Manipal, Max Reportedly Eye KIMS Stake

Max Healthcare Reportedly Eyeing AMRI Hospitals

Price target increased to ₹512

Price target increased to ₹498

KKR, Temasek Reportedly Vie for Care Hospitals; Deal Likely at $1 Billion

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Max Healthcare Institute Limited Announces Management Changes

Max Healthcare Institute Limited to Report Q2, 2023 Results on Nov 01, 2022

Max Healthcare Institute Limited Announces Resignation of Ruchi Mahajan as Company Secretary and Compliance Officer

Max Healthcare Institute Limited Announces Cessation of Prashant Kumar as Non-Executive Non-Independent Director

Investor sentiment improved over the past week

Max Healthcare Institute Limited Announces Resignation of Gaurav Trehan as Non-Executive Non-Independent Director

KKR Reportedly Plans to Exit Max Healthcare by Selling its Entire 27.54% Stake

Max Healthcare Institute Limited, Annual General Meeting, Sep 26, 2022

High number of new directors

Max Healthcare Institute Limited to Report Q1, 2023 Results on Aug 10, 2022

KKR Affiliate Not in Talks for Stake Sale in Max Health

KKR Reportedly May Sell Stake in Max

Full year 2022 earnings: EPS and revenues miss analyst expectations

Ontario Teachers' Pension Plan Board, Max Healthcare Reportedly Lead the Race for Sahyadri Hospitals

Ontario Teachers' Pension Plan Board, Max Healthcare Reportedly Lead the Race for Sahyadri Hospitals

Max Healthcare Institute Limited to Report Q4, 2022 Results on May 25, 2022

High number of new and inexperienced directors

High number of new directors

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited Announces Executive Changes

Max Healthcare Institute Limited to Report Q3, 2022 Results on Feb 12, 2022

Consensus forecasts updated

Price target increased to ₹444

Insider recently sold ₹12m worth of stock

Insider recently sold ₹6.8m worth of stock

Insider recently sold ₹2.3m worth of stock

Price target increased to ₹424

Price target increased to ₹424

Insider recently bought ₹5.4m worth of stock

First quarter 2022 earnings released: EPS ₹1.52

Full year 2021 earnings released: ₹1.59 loss per share (vs ₹1.78 profit in FY 2020)

Independent Director has left the company

Max Healthcare Institute Limited (BSE:543220) completed the acquisition of remaining 42.8% stake in Saket City Hospitals Private Limited from Kayak Investments Holding Pte. Ltd. for INR 4.7 billion.